Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.

× No keyword cloud information.

27 in total

1. [Early therapy of axial spondyloarthritis and relevance of radiological progression].

Authors: I H Song; J Sieper
Journal: Z Rheumatol Date: 2012-01 Impact factor: 1.372

Review 2. The treatment of psoriatic arthritis and inflammatory spondylitis.

Authors: Hernan Castro-Rueda; Arthur Kavanaugh
Journal: Curr Pain Headache Rep Date: 2008-12

Review 3. New evidence on the management of spondyloarthritis.

Authors: Joachim Sieper; Denis Poddubnyy
Journal: Nat Rev Rheumatol Date: 2016-04-07 Impact factor: 20.543

4. Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis.

Authors: Wei Xu; Chao-Ge Liang; Yi-Fan Li; Yun-Han Ji; Wen-Jun Qiu; Xian-Zhong Tang
Journal: Int J Clin Exp Pathol Date: 2015-03-01

5. Dietary hydroxycinnamates prevent oxidative damages to liver, spleen, and bone marrow cells in irradiation-exposed mice.

Authors: Sung-Ho Kook; Sa-Ra Cheon; Jae-Hwan Kim; Ki-Choon Choi; Min-Kook Kim; Jeong-Chae Lee
Journal: Food Sci Biotechnol Date: 2017-02-28 Impact factor: 2.391

6. [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].

Authors: U Kiltz; J Sieper; H Kellner; D Krause; M Rudwaleit; J-F Chenot; A Stallmach; S Jaresch; J Braun
Journal: Z Rheumatol Date: 2014-09 Impact factor: 1.372

7. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.

Authors: Fahimeh Jafarnezhad-Ansariha; Mir Saeed Yekaninejad; Ahmad-Reza Jamshidi; Reza Mansouri; Mahdi Vojdanian; Mahdi Mahmoudi; Mohammad Javad Fattahi; Seyed Naser Hashemi; Bernd H A Rehm; Hidenori Matsuo; Emanuela Esposito; Salvatore Cuzzocrea; Abbas Mirshafiey
Journal: Inflammopharmacology Date: 2017-08-17 Impact factor: 4.473

Review 8. Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis.

Authors: Patompong Ungprasert; Patricia J Erwin; Matthew J Koster
Journal: Clin Rheumatol Date: 2017-05-28 Impact factor: 2.980

Review 9. Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors: Heiner Appel; Joachim Sieper
Journal: Curr Rheumatol Rep Date: 2008-10 Impact factor: 4.592

10. [Diagnosis and therapy of axial spondyloarthritis including ankylosing spondylitis (Bechterew's disease)].

Authors: D Poddubnyy; J Sieper
Journal: Orthopade Date: 2012-07 Impact factor: 1.087